Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
Context | Citation |
---|---|
Increases Bifidobacterium dentium - : Limosilactobacillus reuteri {L. Reuteri} |
👶
Coexpression and secretion of endoglucanase and phytase genes in Lactobacillus reuteri. International journal of molecular sciences (Int J Mol Sci ) Vol: 15 Issue 7 Pages: 12842-60 Pub: 2014 Jul 21 Epub: 2014 Jul 21 Authors Wang L , Yang Y , Cai B , Cao P , Yang M , Chen Y , Html Article Publication |
Increases Bifidobacterium dentium - : Limosilactobacillus reuteri {L. Reuteri} |
👶
Efficacy of Limosilactobacillus reuteri UBLRu-87 in Infantile Colic and Its Symptoms: A Double-Blind, Placebo-Controlled Study. Cureus (Cureus ) Vol: 17 Issue 4 Pages: e81856 Pub: 2025 Apr Epub: 2025 Apr 7 Authors Venkataraman R , Kotyal Basvanyappa M , Samanta B , Yadla M , Ravi NA , Neelamraju J , Madempudi RS , Html Article Publication |
Increases Bifidobacterium dentium - : Limosilactobacillus reuteri {L. Reuteri} |
👶
Differential reinforcement of intestinal barrier function by various Lactobacillus reuteri strains in mice with DSS-induced acute colitis. Life sciences (Life Sci ) Vol: 314 Issue Pages: 121309 Pub: 2023 Feb 1 Epub: 2022 Dec 20 Authors Lin C , Zheng Y , Lu J , Zhang H , Wang G , Chen W , Publication |
0 π | π’ 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]